Bristol Myers Squibb (BMY)
Bristol Myers Squibb on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as pharmaceutical preparations.
49.9M
Short interest
settlement 2026-10-15
3.6
Days to cover
+0.6 days vs prior
56.5%
Short share of volume
2026-10-28
5,176
Fails to deliver
settlement 2026-09-28
Thu 29 Oct
Next earnings
estimated date
-$437K
Insider flow, 90 days
0 buys, 2 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in BMY is 49,948,083 shares, up 7,978,506 shares over the last month. Over the last 48 readings it ranged from 23,421,095 shares (31 October 2024) to 52,336,079 shares (31 July 2026). The latest reading sits at the top of that range. At the reported average volume of 13.7M shares a day that is 3.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/bmy" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 49,948,083 | +8.9% | 13,689,426 | 3.65 |
| 2026-09-30 | 45,847,626 | +9.2% | 15,248,539 | 3.01 |
| 2026-09-15 | 41,969,577 | -4.8% | 7,235,931 | 5.80 |
| 2026-08-31 | 44,073,318 | -3.9% | 8,368,826 | 5.27 |
| 2026-08-14 | 45,852,662 | -12.4% | 13,183,281 | 3.48 |
| 2026-07-31 | 52,336,079 | +16.5% | 11,294,121 | 4.63 |
| 2026-07-15 | 44,935,362 | +10.9% | 10,603,478 | 4.24 |
| 2026-06-30 | 40,531,289 | +2.4% | 16,383,235 | 2.47 |
| 2026-06-15 | 39,595,308 | +2.8% | 11,894,736 | 3.33 |
| 2026-05-29 | 38,507,952 | +4.9% | 11,144,361 | 3.46 |
| 2026-05-15 | 36,716,099 | +17.2% | 10,381,700 | 3.54 |
| 2026-04-30 | 31,330,595 | -3.3% | 9,871,549 | 3.17 |
| 2026-04-15 | 32,393,759 | +2.8% | 9,465,589 | 3.42 |
| 2026-03-31 | 31,501,585 | +5.5% | 15,833,195 | 1.99 |
| 2026-03-13 | 29,852,257 | -10.7% | 11,789,104 | 2.53 |
| 2026-02-27 | 33,420,961 | +5.5% | 13,016,834 | 2.57 |
| 2026-02-13 | 31,674,440 | +6.0% | 14,615,157 | 2.17 |
| 2026-01-30 | 29,894,882 | -19.1% | 12,741,067 | 2.35 |
| 2026-01-15 | 36,975,176 | +1.1% | 12,869,177 | 2.87 |
| 2025-12-31 | 36,577,723 | +3.2% | 16,091,811 | 2.27 |
| 2025-12-15 | 35,431,255 | +4.5% | 16,391,235 | 2.16 |
| 2025-11-28 | 33,891,065 | +7.0% | 14,281,206 | 2.37 |
| 2025-11-14 | 31,685,786 | -1.2% | 14,120,523 | 2.24 |
| 2025-10-31 | 32,070,775 | +5.6% | 17,797,730 | 1.80 |
| 2025-10-15 | 30,358,285 | +15.2% | 17,889,611 | 1.70 |
| 2025-09-30 | 26,343,569 | -10.6% | 19,180,880 | 1.37 |
| 2025-09-15 | 29,470,983 | -5.5% | 9,460,298 | 3.12 |
| 2025-08-29 | 31,193,823 | +5.1% | 9,732,383 | 3.21 |
| 2025-08-15 | 29,689,692 | -4.0% | 11,643,022 | 2.55 |
| 2025-07-31 | 30,920,136 | -19.4% | 13,934,190 | 2.22 |
| 2025-07-15 | 38,384,745 | -2.7% | 12,710,342 | 3.02 |
| 2025-06-30 | 39,446,776 | +17.4% | 17,038,846 | 2.32 |
| 2025-06-13 | 33,614,196 | +3.3% | 11,062,716 | 3.04 |
| 2025-05-30 | 32,544,288 | -12.1% | 12,282,476 | 2.65 |
| 2025-05-15 | 37,006,724 | -0.3% | 18,981,629 | 1.95 |
| 2025-04-30 | 37,123,977 | +23.6% | 16,832,390 | 2.21 |
| 2025-04-15 | 30,034,861 | +2.2% | 15,517,947 | 1.94 |
| 2025-03-31 | 29,399,379 | -20.6% | 11,971,600 | 2.46 |
| 2025-03-14 | 37,010,551 | +21.1% | 13,328,592 | 2.78 |
| 2025-02-28 | 30,571,531 | +19.4% | 11,957,015 | 2.56 |
| 2025-02-14 | 25,592,830 | -4.1% | 13,373,830 | 1.91 |
| 2025-01-31 | 26,695,018 | -3.0% | 10,097,959 | 2.64 |
| 2025-01-15 | 27,515,929 | +10.4% | 9,285,364 | 2.96 |
| 2024-12-31 | 24,932,099 | -9.8% | 13,055,161 | 1.91 |
| 2024-12-13 | 27,657,195 | +8.0% | 9,037,967 | 3.06 |
| 2024-11-29 | 25,600,720 | -0.7% | 9,236,440 | 2.77 |
| 2024-11-15 | 25,773,897 | +10.1% | 13,911,472 | 1.85 |
| 2024-10-31 | 23,421,095 | +4.1% | 8,382,976 | 2.79 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of BMY volume is 56.5%, up 5.3 points over the last five sessions. Over the last 30 readings it ranged from 27.7% (25 September 2026) to 74.9% (18 September 2026). The latest reading is 10.3 points above the 30-session average of 46.3%, on 2.4M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 1.4M | 2.4M | 56.5% | 9,477 |
| 2026-10-27 | 1.5M | 2.6M | 59.4% | 2,790 |
| 2026-10-26 | 1.1M | 2.2M | 51.7% | 2,785 |
| 2026-10-23 | 1.7M | 3.0M | 58.2% | 2,971 |
| 2026-10-22 | 1.7M | 3.4M | 51.3% | 9,193 |
| 2026-10-21 | 1.1M | 2.1M | 51.3% | 2,192 |
| 2026-10-20 | 2.7M | 4.6M | 59.6% | 2,753 |
| 2026-10-19 | 1.6M | 4.3M | 36.6% | 3,387 |
| 2026-10-16 | 1.4M | 3.8M | 35.7% | 4,100 |
| 2026-10-15 | 1.9M | 4.9M | 39.3% | 4,608 |
| 2026-10-14 | 2.2M | 5.0M | 44.0% | 2,398 |
| 2026-10-13 | 2.2M | 5.1M | 42.8% | 4,953 |
| 2026-10-12 | 4.2M | 8.0M | 52.1% | 5,275 |
| 2026-10-09 | 1.0M | 3.4M | 29.4% | 2,661 |
| 2026-10-08 | 1.0M | 3.6M | 28.9% | 1,679 |
| 2026-10-07 | 2.1M | 4.4M | 46.2% | 21,337 |
| 2026-10-06 | 1.2M | 3.7M | 31.2% | 3,469 |
| 2026-10-05 | 2.8M | 6.8M | 42.0% | 9,198 |
| 2026-10-02 | 1.2M | 3.2M | 39.2% | 7,722 |
| 2026-10-01 | 1.7M | 3.2M | 53.5% | 3,082 |
| 2026-09-30 | 2.6M | 3.8M | 66.9% | 1,589 |
| 2026-09-29 | 2.8M | 4.5M | 62.5% | 68 |
| 2026-09-28 | 1.2M | 3.8M | 30.2% | 4,975 |
| 2026-09-25 | 808K | 2.9M | 27.7% | 0 |
| 2026-09-24 | 1.9M | 5.4M | 34.5% | 3,610 |
| 2026-09-23 | 1.2M | 3.0M | 40.2% | 12,457 |
| 2026-09-22 | 1.1M | 2.3M | 46.4% | 3,850 |
| 2026-09-21 | 1.2M | 2.2M | 52.0% | 3,433 |
| 2026-09-18 | 2.8M | 3.8M | 74.9% | 13,971 |
| 2026-09-17 | 1.7M | 3.9M | 44.0% | 1,802 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 28 September 2026, the fails-to-deliver balance in BMY is 5,176 shares, up 5,175 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (4 May 2026) to 347,899 shares (25 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-28 | 5,176 | $62.86 | $325K |
| 2026-09-21 | 1 | $63.06 | $63 |
| 2026-09-03 | 280 | $67.66 | $19K |
| 2026-09-02 | 242 | $66.92 | $16K |
| 2026-08-24 | 73,519 | $67.01 | $4.9M |
| 2026-08-20 | 88,820 | $67.61 | $6.0M |
| 2026-08-13 | 301 | $63.70 | $19K |
| 2026-08-03 | 30 | $65.31 | $2K |
| 2026-07-31 | 62,638 | $64.86 | $4.1M |
| 2026-07-29 | 175 | $63.60 | $11K |
| 2026-07-24 | 734 | $61.51 | $45K |
| 2026-07-22 | 361 | $60.93 | $22K |
| 2026-07-21 | 2,346 | $60.16 | $141K |
| 2026-07-20 | 11,818 | $60.74 | $718K |
| 2026-07-02 | 965 | $56.44 | $54K |
| 2026-06-30 | 2,336 | $58.56 | $137K |
| 2026-06-25 | 347,899 | $55.00 | $19.1M |
| 2026-06-22 | 7,786 | $54.00 | $420K |
| 2026-06-05 | 545 | $56.60 | $31K |
| 2026-06-02 | 27,657 | $54.95 | $1.5M |
| 2026-05-26 | 200 | $59.46 | $12K |
| 2026-05-18 | 753 | $57.00 | $43K |
| 2026-05-07 | 103 | $56.59 | $6K |
| 2026-05-04 | 1 | $58.22 | $58 |
| 2026-05-01 | 6,526 | $60.59 | $395K |
| 2026-04-29 | 7,119 | $58.26 | $415K |
| 2026-04-23 | 5,060 | $58.80 | $298K |
| 2026-04-22 | 1,350 | $59.39 | $80K |
| 2026-04-20 | 16,428 | $60.17 | $988K |
| 2026-04-15 | 15 | $58.08 | $871 |
Insider trades
SEC Form 4, newest first. JSONInsiders at BMY reported 2 open-market sells worth $437K in the last 90 days and no open-market buys. Latest filing: Gallman Cari (EVP, General Counsel) on 2026-10-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Gallman Cari | EVP, General Counsel | Tax withholding | 2K | $61.15 | $143K | 16K |
| 2026-10-02 | Gallman Cari | EVP, General Counsel | Exercise or conversion | 5K | $0.00 | $0 | 18K |
| 2026-09-09 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Sell | 6K | $64.57 | $403K | 19K |
| 2026-09-01 | Short Bartie Wendy | EVP, Corporate Affairs | Tax withholding | 633 | $66.92 | $42K | 13K |
| 2026-09-01 | Short Bartie Wendy | EVP, Corporate Affairs | Exercise or conversion | 1K | $66.92 | $83K | 13K |
| 2026-08-25 | Holzer Phil M | SVP and Controller | Sell | 500 | $67.50 | $34K | 17K |
| 2026-08-01 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Tax withholding | 26K | $65.31 | $1.7M | 25K |
| 2026-08-01 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Exercise or conversion | 51K | $0.00 | $0 | 51K |
| 2026-08-01 | Gallman Cari | EVP, General Counsel | Tax withholding | 543 | $65.31 | $35K | 14K |
| 2026-08-01 | Gallman Cari | EVP, General Counsel | Exercise or conversion | 1K | $0.00 | $0 | 14K |
| 2026-06-15 | Haller Julia A | Director | Exercise or conversion | 20K | $53.76 | $1.1M | 34K |
| 2026-06-03 | Short Bartie Wendy | EVP, Corporate Affairs | Tax withholding | 4K | $54.72 | $212K | 12K |
| 2026-06-03 | Short Bartie Wendy | EVP, Corporate Affairs | Exercise or conversion | 8K | $0.00 | $0 | 16K |
| 2026-05-01 | Lenkowsky Adam | EVP, Chief Commercial Officer | Tax withholding | 599 | $58.22 | $35K | 20K |
| 2026-05-01 | Lenkowsky Adam | EVP, Chief Commercial Officer | Other transaction | 203 | $0.00 | $0 | 20K |
| 2026-05-01 | Lenkowsky Adam | EVP, Chief Commercial Officer | Exercise or conversion | 1K | $0.00 | $0 | 21K |
| 2026-04-01 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Tax withholding | 2K | $61.73 | $104K | 26K |
| 2026-04-01 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Exercise or conversion | 3K | $0.00 | $0 | 28K |
| 2026-04-01 | Elkins David V | EVP, Chief Financial Officer | Sell | 4K | $62.05 | $278K | 159K |
| 2026-04-01 | Elkins David V | EVP, Chief Financial Officer | Sell | 26K | $61.60 | $1.6M | 164K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Tax withholding | 828 | $60.13 | $50K | 8K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Other transaction | 2K | $0.00 | $0 | 9K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Exercise or conversion | 4K | $0.00 | $0 | 11K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Tax withholding | 242 | $60.13 | $15K | 6K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Other transaction | 81 | $0.00 | $0 | 7K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Exercise or conversion | 749 | $0.00 | $0 | 7K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Tax withholding | 205 | $60.13 | $12K | 6K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Other transaction | 72 | $0.00 | $0 | 6K |
| 2026-03-10 | Short Bartie Wendy | EVP, Corporate Affairs | Exercise or conversion | 639 | $0.00 | $0 | 6K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Tax withholding | 849 | $60.13 | $51K | 17K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Other transaction | 2K | $0.00 | $0 | 18K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Exercise or conversion | 5K | $0.00 | $0 | 20K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Tax withholding | 248 | $60.13 | $15K | 16K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Other transaction | 83 | $0.00 | $0 | 16K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Exercise or conversion | 768 | $0.00 | $0 | 16K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Tax withholding | 261 | $60.13 | $16K | 15K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Other transaction | 91 | $0.00 | $0 | 16K |
| 2026-03-10 | Holzer Phil M | SVP and Controller | Exercise or conversion | 811 | $0.00 | $0 | 16K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Tax withholding | 912 | $60.13 | $55K | 8K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Other transaction | 3K | $0.00 | $0 | 9K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Exercise or conversion | 6K | $0.00 | $0 | 12K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Tax withholding | 267 | $60.13 | $16K | 6K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Other transaction | 113 | $0.00 | $0 | 6K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Exercise or conversion | 1K | $0.00 | $0 | 6K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Tax withholding | 212 | $60.13 | $13K | 5K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Other transaction | 94 | $0.00 | $0 | 5K |
| 2026-03-10 | Hoch Lynelle | President, Cell Therapy Org. | Exercise or conversion | 838 | $0.00 | $0 | 6K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Tax withholding | 1K | $60.13 | $76K | 7K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Other transaction | 2K | $0.00 | $0 | 8K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Exercise or conversion | 5K | $0.00 | $0 | 11K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Tax withholding | 367 | $60.13 | $22K | 6K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Other transaction | 87 | $0.00 | $0 | 6K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Exercise or conversion | 803 | $0.00 | $0 | 6K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Tax withholding | 369 | $60.13 | $22K | 6K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Other transaction | 91 | $0.00 | $0 | 6K |
| 2026-03-10 | Poole Ahn Amanda | EVP, Chief People Officer | Exercise or conversion | 811 | $0.00 | $0 | 6K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Tax withholding | 1K | $60.13 | $81K | 13K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Other transaction | 3K | $0.00 | $0 | 14K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Exercise or conversion | 5K | $0.00 | $0 | 17K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Tax withholding | 396 | $60.13 | $24K | 12K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Other transaction | 94 | $0.00 | $0 | 12K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Exercise or conversion | 867 | $0.00 | $0 | 12K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Tax withholding | 415 | $60.13 | $25K | 11K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Other transaction | 102 | $0.00 | $0 | 12K |
| 2026-03-10 | Gallman Cari | EVP, General Counsel | Exercise or conversion | 912 | $0.00 | $0 | 12K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Tax withholding | 2K | $60.13 | $129K | 19K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Other transaction | 4K | $0.00 | $0 | 21K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Exercise or conversion | 8K | $0.00 | $0 | 25K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Tax withholding | 3K | $60.13 | $188K | 17K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Other transaction | 6K | $0.00 | $0 | 20K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Exercise or conversion | 12K | $0.00 | $0 | 26K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Tax withholding | 913 | $60.13 | $55K | 14K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Other transaction | 216 | $0.00 | $0 | 15K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Exercise or conversion | 2K | $0.00 | $0 | 15K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Tax withholding | 831 | $60.13 | $50K | 13K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Other transaction | 205 | $0.00 | $0 | 14K |
| 2026-03-10 | Lenkowsky Adam | EVP, Chief Commercial Officer | Exercise or conversion | 2K | $0.00 | $0 | 14K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Tax withholding | 5K | $60.13 | $309K | 24K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Other transaction | 10K | $0.00 | $0 | 29K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Exercise or conversion | 20K | $0.00 | $0 | 39K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Tax withholding | 2K | $60.13 | $90K | 19K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Other transaction | 356 | $0.00 | $0 | 21K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Exercise or conversion | 3K | $0.00 | $0 | 21K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Tax withholding | 1K | $60.13 | $67K | 18K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Other transaction | 275 | $0.00 | $0 | 19K |
| 2026-03-10 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Exercise or conversion | 2K | $0.00 | $0 | 19K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Tax withholding | 4K | $60.13 | $257K | 30K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Other transaction | 10K | $0.00 | $0 | 35K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Exercise or conversion | 20K | $0.00 | $0 | 44K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Tax withholding | 1K | $60.13 | $75K | 25K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Other transaction | 356 | $0.00 | $0 | 26K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Exercise or conversion | 3K | $0.00 | $0 | 26K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Tax withholding | 1K | $60.13 | $64K | 23K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Other transaction | 319 | $0.00 | $0 | 24K |
| 2026-03-10 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Exercise or conversion | 3K | $0.00 | $0 | 24K |
| 2026-03-10 | Plenge Robert M | EVP, Chief Research Officer | Tax withholding | 3K | $60.13 | $191K | 22K |
| 2026-03-10 | Plenge Robert M | EVP, Chief Research Officer | Other transaction | 7K | $0.00 | $0 | 25K |
| 2026-03-10 | Plenge Robert M | EVP, Chief Research Officer | Exercise or conversion | 14K | $0.00 | $0 | 32K |
| 2026-03-10 | Plenge Robert M | EVP, Chief Research Officer | Tax withholding | 927 | $60.13 | $56K | 18K |
| 2026-03-10 | Plenge Robert M | EVP, Chief Research Officer | Other transaction | 253 | $0.00 | $0 | 18K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON3 Form 144 notices on file for BMY worth $2.3M at the prices reported; 2 in the last 90 days worth $437K. Latest: Massacesi Cristian filed on 2026-09-09 to sell 6,249 shares ($403K) from 2026-09-09.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-09 | Massacesi CristianOfficer | 6K | $403K | 0.000% | 2026-09-09 | Fidelity Brokerage Services LLC |
| 2026-08-25 | Holzer Phil MOfficer | 500 | $34K | 0.000% | 2026-08-25 | Fidelity Brokerage Services LLC |
| 2026-04-01 | Elkins David VOfficer | 30K | $1.9M | 0.001% | 2026-04-01 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of BMY in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (153,108,018 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-07 | 13G | STATE STREET CORPORATIONparent holding company | 102.5M | 5.0% | 2026-06-30 |
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 153.1M | 7.5% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 10 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding BMY at their latest 13F. JSON6 of the 30 tracked managers held BMY at their latest 13F, $2.33B in total at quarter-end prices. AQR Capital Management is the largest at $1.58B (0.5% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 27.4M | $1.58B | 0.55% | -2.3M |
| Two Sigma Investments | 2026-06-30 | 10.1M | $581.1M | 0.42% | -1.4M |
| Citadel Advisors | 2026-06-30 | 1.6M | $90.6M | 0.01% | +78K |
| Millennium Management | 2026-06-30 | 753K | $43.4M | 0.02% | -5.8M |
| D. E. Shaw & Co. | 2026-06-30 | 559K | $32.2M | 0.02% | +250K |
| Fisher Asset Management | 2026-06-30 | 173K | $10.0M | 0.00% | -30K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Bristol Myers Squibb reported revenue of $12.97B, up 5.7% from the same quarter a year earlier, and net income of $3.32B (1.62 diluted EPS). In FY 2025 it generated $14.16B of operating cash flow and spent $5.04B on dividends. As of 2026-06-30, cash was $8.72B against $42.86B of debt.
- Cash
- $8.72B
- Debt
- $42.86B
- Equity
- $22.32B
- Total assets
- $87.63B
- Shares outstanding
- 2,042,714,656
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $12.97B | $3.32B | 25.6% | 1.62 |
| Q1 FY 2026 | 2026-03-31 | $11.49B | $2.68B | 23.3% | 1.31 |
| Q4 FY 2025derived | 2025-12-31 | $12.50B | $1.09B | 8.7% | n/a |
| Q3 FY 2025 | 2025-09-30 | $12.22B | $2.20B | 18.0% | 1.08 |
| Q2 FY 2025 | 2025-06-30 | $12.27B | $1.31B | 10.7% | 0.64 |
| Q1 FY 2025 | 2025-03-31 | $11.20B | $2.46B | 21.9% | 1.20 |
| Q4 FY 2024derived | 2024-12-31 | $12.34B | $72.0M | 0.6% | n/a |
| Q3 FY 2024 | 2024-09-30 | $11.89B | $1.21B | 10.2% | 0.60 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $48.19B | $7.05B | $14.16B | $1.31B | $0 | $5.04B |
| FY 2024 | 2024-12-31 | $48.30B | -$8.95B | $15.19B | $1.25B | $0 | $4.86B |
| FY 2023 | 2023-12-31 | $45.01B | $8.03B | $13.86B | $1.21B | $5.16B | $4.74B |
| FY 2022 | 2022-12-31 | $46.16B | $6.33B | $13.07B | $1.12B | $8.00B | $4.63B |
| FY 2021 | 2021-12-31 | $46.38B | $6.99B | $16.21B | $973.0M | $6.29B | $4.40B |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-22 from the cover page.
What this page is
Bristol Myers Squibb in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Bristol Myers Squibb (BMY), SEC CIK 14272, listed on NYSE, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-28.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-07.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 14272Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
Datasets
Frequently Asked Questions
How much of BMY is sold short?
49,948,083 shares were held short at the 2026-10-15 settlement, 3.6 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is BMY's daily short volume?
On 2026-10-28, 1,375,910 of the 2,433,664 BMY shares reported to FINRA were sold short, 56.5% of the day's reported volume. Short volume is a flow for one day, not a position.
Does BMY have fails to deliver?
The SEC's latest file shows 5,176 BMY shares failed to deliver at settlement 2026-09-28. Fails are reported per settlement date and published twice a month with a lag.
Are BMY insiders buying or selling?
Insiders at BMY reported 2 open-market sells worth $437K in the last 90 days and no open-market buys. Latest filing: Gallman Cari (EVP, General Counsel) on 2026-10-02.
Have BMY insiders filed to sell?
3 Form 144 notices on file for BMY worth $2.3M at the prices reported; 2 in the last 90 days worth $437K. Latest: Massacesi Cristian filed on 2026-09-09 to sell 6,249 shares ($403K) from 2026-09-09.
Who owns 5% or more of BMY?
2 holders report 5% or more of BMY in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (153,108,018 shares), filed 2026-04-29 for an event on 2026-03-31.
What did BMY report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Bristol Myers Squibb reported revenue of $12.97B, up 5.7% from the same quarter a year earlier, and net income of $3.32B (1.62 diluted EPS). In FY 2025 it generated $14.16B of operating cash flow and spent $5.04B on dividends. As of 2026-06-30, cash was $8.72B against $42.86B of debt.
Which tracked 13F managers own BMY?
6 of the 30 tracked 13F managers held BMY shares at their latest filing, $2.33B in all. The largest: Cliff Asness's AQR Capital Management (27.4M shares, $1.58B), Two Sigma Investments (10.1M shares, $581.1M), Ken Griffin's Citadel Advisors (1.6M shares, $90.6M), Izzy Englander's Millennium Management (753K shares, $43.4M), D. E. Shaw & Co. (559K shares, $32.2M), Ken Fisher's Fisher Asset Management (173K shares, $10.0M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.